Pharma Marketletter

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

"Self-correcting balance" between brand, generics firms, both using "c...
December 22, 2003

US Medicare Rx cards to be issued in spring.
December 22, 2003

EU Court upholds ban on Internet Rx sales, OKs on-line and mail-order ...
December 22, 2003

UK drug regulation is flawed, says charity.
December 22, 2003

NDAs rise 20% as R&D, marketing unite: study.(Brief Article)
December 22, 2003

EU biopharma sector growth threatened by funding shortfalls, capacity ...
December 22, 2003

Near-term risks versus long-term upside at Germany's Altana assessed b...
December 22, 2003

Stem cell products: a $10B market in 2013?(Brief Article)
December 22, 2003

Sanofi-Synthelabo wins UK marketing award.(Brief Article)
December 22, 2003

AstraZeneca's Prilosec patents upheld in USA.(Brief Article)
December 22, 2003

Amylin files shelf registration for $300M securities sale.(Brief Artic...
December 22, 2003

Pharmaceutical marketing "in crisis," says report; new business models...
December 22, 2003

deCODE isolates two new obesity genes in accord with Merck.(Brief Arti...
December 22, 2003

Novotech begins trial of Angiogenix' Acclaim.(Brief Article)
December 22, 2003

Tularik and Sankyo advance GPCR drug discovery deal.(Brief Article)
December 22, 2003

HIV vaccine begins small-scale clinical trial in Belgium.(Brief Articl...
December 22, 2003

Genaissance and Ferring sign pharmacogenomics accord.(Brief Article)
December 22, 2003

Salix' antibiotic to get FDA decision by May.(Brief Article)
December 22, 2003

Clinical trials start for Procleix Ultrio Assay.(Brief Article)
December 22, 2003

Schering AG's Finacea cleared in EU.(Brief Article)
December 22, 2003

Acambis files vaccine BLA with FDA.(Brief Article)
December 22, 2003

Australia and New Zealand sign Rx treaty.(Brief Article)
December 22, 2003

GSK and BI to seek only 5% royalty rate on South African ARV licenses....
December 22, 2003

Mylan's Ertaczo cleared by FDA.(Brief Article)
December 22, 2003

Promising new data for GSK's nelarabine.(Brief Article)
December 22, 2003

Roche's CERA corrects anemia in MM patients.(Continuous Erythropoiesis...
December 22, 2003

Genzyme starts Ph I trial for MS therapy.(Brief Article)
December 22, 2003

World Rx sales up 7% in year to October.(Brief Article)
December 22, 2003

Australian PBS "being used to ration care".(Brief Article)
December 22, 2003

China's GMP deadline.(Good Manufacturing Practice)(Brief Article)
December 22, 2003

Zimbabwe govt to help source foreign drugs.(Brief Article)
December 22, 2003

Japan urged to limit non-Rx drug sales.(Brief Article)
December 22, 2003

Roche signs Japanese deal with Chugai.(Brief Article)
December 22, 2003

Aventis' Ketek launched in Japan.(Brief Article)
December 22, 2003

GSK review awards CEO $10M package.(Brief Article)
December 22, 2003

Drugmakers warned by KPMG about over-optimistic predictions.
December 22, 2003

Tokyo pharma stocks - week to Dec 15.
December 22, 2003

UK govt/Rx "implicit" PPP is flawed, says study; calls for Health R&D ...
December 22, 2003

Metformin GR meets goal in Ph III trial.(Brief Article)
December 22, 2003

DX-890 gets Orphan Drug status from FDA.(Brief Article)
December 22, 2003

New pharma plants in Vietnam.(Brief Article)
December 22, 2003

Antidepression drug market forecasts 2003-8.(Brief Article)
December 22, 2003

UCB Pharma's Keppra effective in controlling seizures in the elderly.
December 22, 2003

Millennium halts Velcade trial early.(Brief Article)
December 22, 2003

aaiPharma reaffirms 2003 forecast.(Brief Article)
December 22, 2003

Bayer books $2.53 bill charge to 4th quarter.(Brief Article)
December 22, 2003

Idenix files with SEC for US IPO.(Brief Article)
December 22, 2003

Schwarz wins US Losec generics battle.(Brief Article)
December 22, 2003

French medical unions move against govt.(Brief Article)
December 22, 2003

Bayer and Galapagos in target discovery deal.(Brief Article)
December 22, 2003

Wyeth prices $850 million debentures float.(Brief Article)
December 22, 2003

Pfizer to buy back $5 bill of comon stock.(Brief Article)
December 22, 2003

Sanofi/Aventis rumors resurface; shares rise on prospect of new Europe...
December 22, 2003

Amgen forecasts 18%-30% rise in 2004 profits, boosted by lead drugs.
December 22, 2003

Recordati looks to expand with acquisitions.(Brief Article)
December 22, 2003

Treatment with Alkermes/J&J's Risperdal Consta may have economic benef...
December 22, 2003

La Jolla submits Riquent NDA to FDA.(Brief Article)
December 22, 2003

Italian Minister urges single EU drug price.(Brief Article)
December 22, 2003

EU Parliament adopts compromise pharma legislative review package.
December 22, 2003

Elan seeks binding Pfizer rights decision.(Brief Article)
December 22, 2003

Spain's Genetrix seeks key licensing deals.(Brief Article)
December 22, 2003

Henderson sees losses widen.(Brief Article)
December 22, 2003

Pharmagene's shares hit high on Bayer deal.(Brief Article)
December 22, 2003

Pharmagene starts Ph II trial of PGN0052.(Brief Article)
December 22, 2003

AstraZeneca's Naropin gets new use in EU.(Brief Article)
December 22, 2003

Tularik's T487 advances to Ph II.(Brief Article)
December 22, 2003

Orion's Stalevo available in the UK.(Brief Article)
December 22, 2003

Novacea signs accord with KuDOS.(Brief Article)
December 22, 2003

MS-325 on track for US approval.(Brief Article)
December 22, 2003

SPECTRUM.(Illustration)
December 22, 2003

Stock Commentary - New York.(Brief Article)
December 22, 2003

Stock Commentary - Europe.
December 22, 2003

GlaxoSmithKline announces board and committee changes.(Brief Article)
December 22, 2003

Novartis buys B-MS's adult medical nutrition business.(Brief Article)
December 22, 2003

Robert Madelin moves to health role at EU Commission.(Brief Article)
December 22, 2003

Page 1|2|3|4|5|6